Epigral

Epigral Net Debt/FCF

The Net Debt to Free Cash Flow Ratio of Epigral (EPIGRAL.NS) as of Oct 21, 2026 is 2.00. In the previous year, Net Debt to Free Cash Flow Ratio was -1,212.31 — a change of -100.17% (higher).

Net Debt/FCF

2.00

YoY

-100.17%

Last updated:

Net Debt to Free Cash Flow Ratio of Epigral is 2025 2.00 . Net Debt to Free Cash Flow Ratio of Epigral was 2024 -1,212.31 . It decreases by -100.17% higher compared to the previous year.

The Epigral Net Debt/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt/FCF
Date
Net Debt/FCF
Jan 1, 2018
-0.02 INR
Jan 1, 2019
-6.31 INR
Jan 1, 2020
-2.59 INR
Jan 1, 2021
16.70 INR
Jan 1, 2022
-4.39 INR
Jan 1, 2023
4.03 INR
Jan 1, 2024
-1,212.31 INR
Jan 1, 2025
2.00 INR
The Epigral Net Debt/FCF history
YEARNet Debt/FCFYoY
2.00-100.17%
-1,212.31-30,171.96%
4.03-191.84%
-4.39-126.28%
16.70-744.03%
-2.59-58.90%
-6.31+28,715.14%
-0.02—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Epigral Stock analysis

What does Epigral do? Meghmani Finechem Ltd. generates revenue through the manufacturing and sale of chemical products including chlor alkali derivatives, CPVC resin, caustic soda, caustic potash, chlorine, hydrogen, chloromethanes, and hydrogen peroxide. The company serves industries such as alumina, textile, crop protection, refineries, pharmaceutical, paper & pulp, and soaps & detergent. Its subsidiary Meghmani Advanced Sciences Limited supports the business operations. The firm also trades agrochemical products to meet agricultural sector demands. The primary buyers of Meghmani Finechem's products are industrial clients across multiple sectors including textile, pharmaceutical, and crop protection. These customers rely on the company's chemical solutions for their production processes. The company's focus on chlor alkali and derivative manufacturing positions it as a key supplier in the chemical industry. Agrochemical trading complements its core chemical manufacturing business. Meghmani Finechem Ltd. operates with a product portfolio centered around chlor alkali and its derivatives, which are essential for various industrial applications. The company's manufacturing capabilities include producing CPVC resin and other specialty chemicals. Its subsidiaries and product range cater to both industrial and agricultural markets. The firm's revenue streams are derived from direct sales to industrial clients and agrochemical trading activities. Epigral is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Epigral stock

Net Debt to Free Cash Flow Ratio of Epigral is 2.00 in 2025.

Net Debt to Free Cash Flow Ratio of Epigral changed from -1,212.31 to 2.00, representing a -100.17% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt to Free Cash Flow Ratio Epigral since 2006 – with annual values, charts, and detailed analysis.

Net Debt/FCF indicates how many years it would take to repay net debt using free cash flow. Lower ratios suggest faster deleveraging potential.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Debt to Free Cash Flow Ratio's Epigral with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Epigral

All Key Metrics — Epigral